Enhanced rational protein engineering to reduce viscosity in high-concentration IgG1 antibody solutions
Subcutaneous (SC) delivery of therapeutic antibodies can offer multiple benefits to patients and healthcare providers, including convenience, time savings, and cost reduction. To improve the SC injection experience, drug developers may seek a low injection volume (1–2 mL), which for some antibody dr...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis Group
2025-12-01
|
| Serie: | mAbs |
| Soggetti: | |
| Accesso online: | https://www.tandfonline.com/doi/10.1080/19420862.2025.2543771 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|